deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT03425422

ANTHEM-HFrEF Pivotal Study

Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure With Reduced Ejection Fraction

Sponsor: LivaNova

Conditions Heart Failure Heart Failure, Congestive Heart Failure, Systolic
Interventions VITARIA System
Updated 16 times since 2018 Last updated: Oct 6, 2023 Started: May 1, 2018 Primary completion: May 31, 2023 Completion: May 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Company decision to stop enrolling not associated with any safety concerns.

Other terminated trials from LivaNova

See all terminations from LivaNova

Other Heart Failure trials with similar outcome

Browse all Heart Failure trials

A NA clinical study on Heart Failure and Heart Failure, Congestive, this trial is terminated or withdrawn. The trial is conducted by LivaNova and has accumulated 16 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2019 · 14 months · monthly snapshot~Sep 2019 – ~Dec 2019 · 3 months · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Feb 2022 · 11 months · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Jul 2022 · 4 months · monthly snapshot~Jul 2022 – ~Apr 2023 · 9 months · monthly snapshot~Apr 2023 – ~Nov 2023 · 7 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Nov 2023 — Jul 2024 [monthly]

    Terminated NA

    Status: Active Not Recruiting → Terminated

  4. Apr 2023 — Nov 2023 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  5. Jul 2022 — Apr 2023 [monthly]

    Recruiting NA

▶ Show 11 earlier versions

  1. Mar 2022 — Jul 2022 [monthly]

    Recruiting NA

  2. Feb 2022 — Mar 2022 [monthly]

    Recruiting NA

  3. Mar 2021 — Feb 2022 [monthly]

    Recruiting NA

  4. Jan 2021 — Mar 2021 [monthly]

    Recruiting NA

  5. Apr 2020 — Jan 2021 [monthly]

    Recruiting NA

  6. Feb 2020 — Apr 2020 [monthly]

    Recruiting NA

  7. Dec 2019 — Feb 2020 [monthly]

    Recruiting NA

  8. Sep 2019 — Dec 2019 [monthly]

    Recruiting NA

  9. Jul 2018 — Sep 2019 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  10. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting NA

  11. Mar 2018 — Jun 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • LivaNova
Data source: LivaNova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United States , Boston, United States , Burlington, United States , Cleveland, United States , Hartford, United States , Hershey, United States , Houston, United States , Jackson, United States , Jacksonville, United States , Little Rock, United States and 12 more locations